early-stage research and development. The company’s offerings include antibody discovery, genetic medicine technologies, cell therapy platforms, and other modalities that enable researchers to design and evaluate potential treatments. It integrates computational approaches such as artificial intelligence with laboratory-based experimentation to improve the efficiency and accuracy of drug discovery processes. Additionally, the company reinvests its revenue into advancing its technologies and expanding access to its services for partners across the scientific community.